(Press-News.org) Scientists use small molecule that suppresses cancer-causing genes in glioblastoma
Nanotechnology crosses blood-brain barrier to reach tumor cells
Approach has potential to silence genes in other cancers and genetic diseases
CHICAGO --- Northwestern Medicine scientists have identified a small RNA molecule called miR-182 that can suppress cancer-causing genes in mice with glioblastoma mulitforme (GBM), a deadly and incurable type of brain tumor.
While standard chemotherapy drugs damage DNA to stop cancer cells from reproducing, the new method stops the source that creates those cancer cells: genes that are overexpressing certain proteins.
"Our study identified miR-182 as a glioblastoma tumor suppressor that reduces the expression of several oncogenes that promote cancer development," said senior author of the study Alexander Stegh, an assistant professor in the Ken and Ruth Davee department of neurology and of medicine at Northwestern University Feinberg School of Medicine.
The study, published April 2 in Genes and Development, used a nanostructure called spherical nucleic acids (SNAs) to safely deliver miR-182 across the blood-brain barrier to reach tumor cells. There it directly targeted multiple oncogenes at once, increasing cancer cell death and reducing cancer cell growth. SNAs are composed of multiple strands of DNA and RNA densely arranged around a nanoparticle center.
"We demonstrate a more specific, more personalized approach to therapy," Stegh said. "SNAs are a very promising platform to silence the particular genes that drive or contribute to cancer progression in individual patients."
There are 16,000 new cases of the deadly brain tumor reported in the U.S. every year. Patients have a very poor prognosis, with median survival of just 14 to 16 months.
The molecule miR-182 is a microRNA, a type of short non-coding RNA that can bind to hundreds of genes to reduce their protein expression in cells. Looking at large-scale genomic datasets, Stegh and colleagues saw that patients with higher levels of miR-182 had a better chance of surviving glioblastoma mulitforme longer.
In the study, they found that miR-182 suppressed Bcl2L12, a cancer gene that blocks cancer cell death in response to chemo- and radiation therapy. The microRNA also impeded two other oncogenes, c-Met and HIF2A. The next challenge was establishing a way to get miR-182 to those specific targets.
The solution was in SNAs, a structure invented by Northwestern colleague and co-author Chad Mirkin, the George B. Rathmann Professor of Chemistry at the Weinberg College of Arts and Sciences and a professor of medicine at Feinberg.
"We designed a novel delivery method for miR-182 using SNAs," Stegh said. "Small gold nanoparticles are conjugated with miR-182 sequences. They cross the blood-brain/blood-tumor barrier, and accumulate within brain tumor sites, where they target oncogenes, regulate cell growth and differentiation, reduce tumor burden and prolong survival in our mouse models."
SNAs have unique properties that allow them to reach cells safely without causing toxicity or activating the immune system.
"Our approach to gene silencing has not been demonstrated before in such a powerful way for the treatment of brain cancers," Stegh said. "These particles, microRNA based SNAs, could also potentially be used for gene silencing in other cancers and diseases of genetic origin."
Additional studies will be needed to test miR-182 and the nanoparticle delivery before it becomes an option for patients with glioblastoma mulitforme. But first, Stegh and colleagues want to hone the particle design and to investigate treatments that combine miR-182 with established chemotherapy drugs in mouse models.
INFORMATION:
This study was supported by the Center for Cancer Nanotechnology Excellence initiative of the National Institutes of Health (NIH) grant U54 CA151880; National Institute of Arthritis and Musculoskeletal and Skin Diseases/NIH grants R01AR060810 and R21AR062898; Dixon Translational Research Grants Initiative of the Northwestern Memorial Foundation; James S. MacDonnell 21st Century Initiative; Coffman Charitable Trust; NIH National Cancer Institute award F32CA171949; and Defense Advanced Projects Agency (DARPA) Cooperative Agreement No. HR0011-13-2-0018.
Additional authors include Fotini Kouri, Lisa Hurley, Weston Daniel, Emily Day, Youjia Hua, Liangliang Hao, Chian-Yu Peng, Timothy Merkel, Markus Queisser, Carissa Ritner, C. David James, Jacob Sznajder, John Kessler and Marcus Peter, all from Northwestern; Hailei Zhang and Lynda Chin from the Broad Institute of Harvard and MIT; and David Giljohann from AuraSense Therapeutics.
Editor's note: Chad Mirkin has interest in AuraSense Therapeutics, a startup biotechnology company that is commercializing spherical nucleic acid-based therapeutics and licensed the SNA technology from Northwestern University. Mirkin is a co-founder of the company.
NORTHWESTERN NEWS: http://www.northwestern.edu/newscenter/
ROCHESTER, Minn. -- Recent large-scale genomic analyses have uncovered dozens of common genetic variants that are associated with breast cancer. Each variant, however, contributes only a tiny amount to a person's overall risk of developing the disease.
A Mayo Clinic-led team of international researchers has now combined 77 of these common genetic variants into a single risk factor that can be used to improve the identification of women with an elevated risk of breast cancer. This factor, known as a polygenic risk score, was built from the genetic data of more than 67,000 ...
If a time machine was available, would it be right to kill Adolf Hitler when he was still a young Austrian artist to prevent World War II and save millions of lives? Should a police officer torture an alleged bomber to find hidden explosives that could kill many people at a local cafe? When faced with such dilemmas, men are typically more willing to accept harmful actions for the sake of the greater good than women. For example, women would be less likely to support the killing of a young Hitler or torturing a bombing suspect, even if doing so would ultimately save more ...
HOUGHTON, Mich. (April 3, 2015): Central Appalachian forests have been experiencing the effects of a changing climate for decades, and effects such as more heavy rainfall events, more drought, and more hot days are likely to continue, according to a new vulnerability assessment for the region by the U.S. Forest Service and many partners.
The assessment describes effects of climate change that have already been observed, projected changes in the climate and the landscape, and forest vulnerabilities for nine forest ecosystem types in a 29-million-acre area of Ohio, West ...
(New York, NY) April 3, 2015 - The scientific community is facing a 'pollution problem' in academic publishing, one that poses a serious threat to the "trustworthiness, utility, and value of science and medicine," according to one of the country's leading medical ethicists.
Arthur L. Caplan, PhD, director of the Division of Medical Ethics in the Department of Population Health at NYU Langone Medical Center, shares these and other observations in a commentary publishing April 3 in the journal Mayo Clinic Proceedings.
"The pollution of science and medicine by plagiarism, ...
Deaths within 30 days of children's heart surgery have almost halved in the UK over the past decade, despite a rise in the number and complexity of cases during that period, reveals an analysis of national data, published in the online journal Open Heart.
The findings prompt the researchers to suggest that it is now time to shift the focus to longer term survival and other issues that matter greatly to patients and their families, such as measures of ill health and impact on functional capacity.
Children's heart surgery in the UK has come under intense public scrutiny ...
Passive exposure to bleach in the home is linked to higher rates of childhood respiratory and other infections, suggests research published online in Occupational & Environmental Medicine.
Although modest, the results are of public health concern in light of the widespread use of bleach in the home, say the researchers, who call for further more detailed studies in this area.
The researchers looked at the potential impact of exposure to bleach in the home among more than 9000 children between the ages of 6 and 12 attending 19 schools in Utrecht, The Netherlands; 17 ...
Highlights
High parathyroid hormone levels and subsequent bone loss are major risk factors for worsening of coronary artery calcification in patients on dialysis.
Washington, DC (April 2, 2015) -- Bone loss may be a sign of poor heart health in patients on dialysis, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). Monitoring bone loss in dialysis patients may therefore provide an early alert to physicians concerning cardiovascular problems.
Most patients with chronic kidney disease who are on dialysis ...
Using archival data from the Japan-led Suzaku X-ray satellite, astronomers have determined the pre-explosion mass of a white dwarf star that blew up thousands of years ago. The measurement strongly suggests the explosion involved only a single white dwarf, ruling out a well-established alternative scenario involving a pair of merging white dwarfs.
"Mounting evidence indicates both of these mechanisms produce what we call type Ia supernovae," said lead researcher Hiroya Yamaguchi, an astrophysicist at NASA's Goddard Space Flight Center in Greenbelt, Maryland. "To understand ...
Boston, MA - Harvard T.H. Chan School of Public Health researchers are calling upon police in all states to improve their reporting of crashes involving vehicles and bicycles, according to a new study being published Thursday, April 2, 2015. Currently, details on crashes are handwritten by police on paper and there are few bicycle-relevant codes. The researchers are calling for police to use electronic tablets that would include more options to gather bicycle-specific data, such as drawings of the scene and additional codes that could indicate, for example, if the bicyclist ...
LOS ANGELES -- Using herpesvirus, molecular immunologists from the University of Southern California (USC) Norris Comprehensive Cancer Center have discovered a cellular process that activates a critical immune defense against pathogens, which could have implications for developing drugs to bolster one's immunity to infection. Some herpesvirus infections lead to cancer.
Led by Pinghui Feng, Ph.D., associate professor of molecular microbiology and immunology at the Keck School of Medicine of USC, the team found that herpesvirus proteins activate retinoic acid-induced gene ...
